Reversible lesion of the corpus callosum associated with COVID-19: A case report
dc.authorid | 0000-0001-7069-769X | en_US |
dc.contributor.author | Gemici, Yagmur Inalkac | |
dc.contributor.author | Tasci, Irem | |
dc.date.accessioned | 2022-03-11T07:06:24Z | |
dc.date.available | 2022-03-11T07:06:24Z | |
dc.date.issued | 2021 | en_US |
dc.department | MTÖ Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect the central nervous system and peripheral nervous system. Major central nervous system manifestations of SARS-CoV-2 infection include seizures, meningoencephalitis, ischemic stroke, anosmia, and hypogeusia. The reversible splenial lesion syndrome was first described in 2004. Although reversible splenial lesion syndrome was initially recognized as a benign phenomenon, a second type of reversible splenial lesion syndrome was identified in later years, which has a poorer prognosis and potentially serious sequela. Reversible splenial lesion syndrome can be caused by numerous etiologies including viruses. In this report, we present a rare case of COVID-19 with reversible splenial lesion, who presented with ataxia and dizziness. | en_US |
dc.identifier.citation | Gemici, Y. I., & Tasci, I. (2021). Reversible lesion of the corpus callosum associated with COVID-19: A case report. Neurology Asia, 26(4), 821-824. | en_US |
dc.identifier.doi | 10.54029/2021vmw | |
dc.identifier.endpage | 824 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 821 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12899/597 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000741407400025 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.institutionauthor | Tasci, Irem | |
dc.language.iso | en | en_US |
dc.relation.ispartof | Neurology Asia | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVİD-19 | en_US |
dc.subject | encephalitis | en_US |
dc.subject | splenıum of the corpus callosum | en_US |
dc.title | Reversible lesion of the corpus callosum associated with COVID-19: A case report | en_US |
dc.type | Article | en_US |